Sanofi to buy PE-backed Amunix Pharmaceuticals
Sanofi has agreed to acquire Amunix Pharmaceuticals, Inc., an immuno-oncology company.
21 December 2021•4 mins read
Sanofi has agreed to acquire Amunix Pharmaceuticals, Inc., an immuno-oncology company.
Walter Capital Partners takes significant stake in Quebec educational games maker Passe-Temps
14 hours ago · 1 min read
Truelink Capital’s GES buys CSG Creative from National Trade Productions
14 hours ago · 2 mins read
MPE Partners’ Intermatic adds outdoor lighting-control products maker Sun-Tech
14 hours ago · 2 mins read
Velocity Capital Management backs founder Griffin Haddrill with stake in LV8, Mirage
15 hours ago · 1 min read
Aterian’s Outlook Group completes acquisition of Graham-backed ABX’s Pewaukee packaging facility
15 hours ago · 1 min read
FPE Capital’s NoBlue2 adds PeopleWalking’s Spanish NetSuite business in Europe push
15 hours ago · 1 min read
PE targets identity security as AI transforms threats: 6 deals
17 hours ago · 3 mins read
